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Approximately 340 million kilograms of
agricultural pesticide active ingredient is used
annually in the United States (Donaldson
et al. 2002), and 85% of U.S. households
store at least one pesticide for home use
(Adgate et al. 2000; Whitmore et al. 1992).
In 1993, the National Resource Council
raised concerns that high levels of environ-
mental pesticide exposure could compromise
the health of U.S. children (National
Research Council 1993). The Food Quality
Protection Act of 1996, to address these con-
cerns, mandates that the U.S. Environmental
Protection Agency limit the amount and type
of pesticides on food to levels deemed safe for
children. In response to this legislation, sev-
eral studies have measured the extent of pesti-
cide exposure among the general public.
Recent biologic monitoring studies indicate
that pesticide exposures are widespread in the
U.S. population, including children [Adgate
et al. 2001; Barr et al. 2004; Centers for
Disease Control and Prevention (CDC)
2001; Curl et al. 2003; Fenske et al. 2000;
Koch et al. 2002; Loewenherz et al. 1997; Lu
et al. 2000; O’Rourke et al. 2000; Shalat
et al. 2003].
Few studies to date have focused speciﬁ-
cally on exposure of children in utero. Those
that have, however, indicate that pregnant
women in the United States experience fre-
quent exposures to pesticides (Berkowitz et al.
2003; CDC 2004; Eskenazi et al. 2004;
Perera et al. 2003; Whyatt and Barr 2001;
Whyatt et al. 2003). In a sample of 386 preg-
nant New York City women, Berkowitz et al.
(2003) reported detectable urinary metabo-
lites for pyrethroids, pentachlorophenol, and
chlorpyrifos in 95, 94, and 80% of study par-
ticipants, respectively. Whyatt et al. (2003)
and Perera et al. (2003) have detected diazi-
non and chlorpyrifos in the air and dust of
New York City homes and in the blood sam-
ples of pregnant women residing within
them. Finally, studies have found metabolites
for organophosphates (OPs), pentachlorophe-
nol, naphthalene, ortho-phenylphenol, and
several other pesticides in amniotic fluid
(Bradman et al. 2003) and infant meconium
(Whyatt and Barr 2001). Overall, these stud-
ies indicate that detectable pesticide exposures
are occurring among pregnant women and
their fetuses.
In the present study, we report OP metabo-
lite levels in urine samples collected during and
just after pregnancy from a low-income, pri-
marily Latina cohort of women residing in an
agricultural region of California.
Materials and Methods
Study location characteristics. The Center for
the Health Assessment of Mothers and
Children of Salinas (CHAMACOS) is a com-
munity/university partnership investigating
environmental allergen, pesticide, and other
toxicant exposures experienced by women
and children in Salinas Valley, California, an
agricultural area. In 2001, approximately
240,000 kg of OP pesticide active ingredient
were applied in this area, a level typical of
recent years (California Department of
Pesticide Regulation 2001). Of these pesti-
cides, 42% were dimethyl OP pesticides,
38% were diethyl OP pesticides, and 20%
did not devolve into a dialkyl phosphate
(DAP) metabolite. In addition, approxi-
mately 5% of study participants reported
home use of OP pesticides, although > 40%
used other classes of pesticides in the home
(Bradman A, unpublished data).
Study population. Between September
1999 and November 2000, 601 pregnant
women were enrolled in the CHAMACOS
birth cohort study. Women were contacted at
six local prenatal clinics. Women were eligible
to participate in this study if they were ≤ 20
weeks’ gestation at the time of enrollment, were
≥ 18 years of age, were qualified to receive
poverty-based government health insurance,
and planned to continue receiving prenatal care
at a participating health center. Written
informed consent was obtained from all partici-
pants in accordance with procedures approved
by the University of California Berkeley
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Little information has been published about pesticide exposures experienced by pregnant women.
We measured six dialkyl phosphate (DAP) urinary metabolites of organophosphate (OP) pesti-
cides in 600 pregnant, low-income women living in the Salinas Valley, California, an agricultural
area. A total of 28% were employed as farm ﬁeldworkers during pregnancy, and 81% had at least
one household member who worked in agriculture. Samples were collected twice during preg-
nancy (mean = 13 and 26 weeks’ gestation, respectively) and just after delivery (mean = 9 days). As
in other studies, dimethyldithiophosphate levels were higher than those of other urinary OP
metabolites. Total DAP metabolite levels in samples collected after delivery were higher than in
samples collected during pregnancy. Median metabolite levels at the ﬁrst and second prenatal sam-
pling points and at the postpartum collection were 102.8, 106.8, and 227.2 nmol/L, respectively.
Both prenatal and postpartum metabolite levels were higher in these Salinas Valley women than in
a sample of women of childbearing age in the general U.S. population (National Health and
Nutrition Examination Survey), although the deviation from U.S. reference levels was most pro-
nounced after delivery. Higher DAP metabolite levels in the immediate postpartum period may
have implications for estimating dose during pregnancy and for exposure during lactation.
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women. Environ Health Perspect 113:1802–1807 (2005). doi:10.1289/ehp.7894 available via
http://dx.doi.org/ [Online 18 July 2005]Committee for the Protection of Human
Subjects. Detailed descriptions of the Salinas
Valley study area and the CHAMACOS study
population have been published previously
(Eskenazi et al. 2003).
Interviews. Participants’ demographic,
health, and household information was col-
lected through personal interviews. Interviews
were conducted in English or Spanish by
bilingual, bicultural study staff. A baseline
interview occurred shortly after enrollment in
the study, generally at 13 weeks’ gestation
[mean (± SD) = 13.4 ± 5.2 weeks’ gestation].
Follow-up interviews occurred at approxi-
mately 26 weeks’ gestation (mean ± SD =
25.9 ± 2.6 weeks’ gestation) and after delivery
(mean ± SD = 8.8 ± 17.9 days). Urine sam-
ples were collected at each interview.
Gestational age at urine collection was cal-
culated for most women using the clinical esti-
mate of gestational age at birth noted in the
medical record. For women who miscarried or
dropped from the study before delivery, gesta-
tional age was calculated using the reported
date of last menstrual period and, when possi-
ble, verified by ultrasound (Eskenazi et al.
2004).
Urine collection and analysis. Spot urine
samples were collected according to the pro-
cedures outlined by the CDC for use in the
National Health and Nutrition Examination
Survey (NHANES) 1999–2000 (CDC 2003).
Women voided into a sterile urine cup in
bathroom facilities at our ﬁeld ofﬁce or in the
CHAMACOS mobile clinic. Specimens were
aliquoted into precleaned glass containers with
Teflon-lined caps, bar coded, and stored at
–80°C until shipment. Samples were shipped
on dry ice to the CDC and stored at –70°C
until analysis.
Pesticide and creatinine measurement. We
measured six nonspeciﬁc urinary OP metabo-
lites, including three dimethyl phosphates,
dimethylphosphate (DMP), dimethyldithio-
phosphate (DMDTP), and dimethylthiophos-
phate (DMTP); and three diethyl phosphates,
diethylphosphate (DEP), diethyldithiophos-
phate (DEDTP), and diethylthiophosphate
(DETP). Urine specimens were codistilled
with acetonitrile. The DAP metabolites were
derivatized to their chloropropyl esters. The
concentrated extracts were then analyzed by
isotope dilution gas chromatography–tandem
mass spectrometry (Bravo et al. 2002), which
is widely regarded as the deﬁnitive technique
for trace analysis with DAP metabolite detec-
tion limits of ≤ 1 ppb (Barr et al. 1999; Shealy
et al. 1996). Creatinine concentrations in
urine were determined using a commercially
available diagnostic enzyme method (Vitros
CREA slides, Ortho Clinical Diagnostics,
Raritan, NJ).
Laboratory quality control (QC) included
repeat analysis of two in-house urine pools
enriched with known amounts of pesticide
residues whose target values and confidence
limits were previously determined (Westgard
2003). Detection limits ranged from 0.05 µg/L
for DEDTP to 1.2 µg/L for DMP. A total of
135 laboratory and 121 (blind) ﬁeld QC sam-
ples were analyzed, representing 16% of total
samples. Mean relative recoveries for six
metabolites in laboratory QC samples ranged
from 98 to 105% [coefficients of variation
(CVs) ranged from 11 to 15%]. Average recov-
ery of total DAP metabolites in field spikes
ranged from 92 to 103% (CVs ranged from 4
to 9%). The mean level of DAP metabolites in
32 blank ﬁeld samples was < 1 µg/L.
We assigned an imputed value of the limit
of detection (LOD)/√2 to levels below the
detection limit (Barr et al. 1999; Hornung
and Reed 1990). Because many OP pesticides
devolve to more than one metabolite in their
class (diethyl or dimethyl phosphates), quan-
tities were converted to molar concentrations
(nanomoles per liter) and summed to obtain
the total concentrations of the diethyl and
dimethyl phosphates.
The creatinine concentration in each urine
sample was reported in milligrams of creatinine
per deciliter of urine. One sample with missing
creatinine concentration data and three urinary
creatinine levels that implied unreasonably
high fluid consumption rates (< 10 mg/dL)
were excluded from statistical analyses.
Of the 601 women who enrolled in the
study, adequate urine samples with credible
creatinine levels were collected from 590
(98%) women at the first prenatal sampling
point, 498 (83%) women at the second pre-
natal sampling point, and 489 (81%) women
after delivery.
Data analysis. The primary objective of
this analysis was to present descriptive infor-
mation about urinary OP metabolite levels
during and soon after pregnancy. Geometric
means and percentiles for individual and total
dimethyl phosphate metabolites, individual
and total diethyl phosphate metabolites, and
total DAP metabolites were calculated for
each sampling time point.
Total DAP metabolite concentrations were
log-normally distributed, whereas the dimethyl
and diethyl phosphate molar concentrations
were not. Thus, we used the Spearman’s rank
test to assess the correlation of metabolites
(untransformed) between the different sam-
pling points. We used general estimating equa-
tions (STATA GEE population-averaged
model; StataCorp, College Station, TX) to
determine the within- and between-individual
variability for the 485 women with two meas-
urements during pregnancy. We used paired
t-tests and binary tests of proportions to com-
pare each prenatal urinary metabolite measure-
ment with the postpartum measurement. In
addition, we calculated each participant’s ratio
of DEP to DETP + DEDTP and DMP to
DMTP + DMDTP metabolites at the three
urine collection time points and then calcu-
lated the mean and median of these ratios.
Finally, we used the Kolgomorov-Smirnov test
of equality of distributions to compare the
pregnancy and postpartum metabolite levels.
We also used the Kolgomorov-Smirnov test
and quantile regression to compare levels for
the CHAMACOS cohort with levels measured
at the same CDC laboratory for women partic-
ipating in NHANES, a cross-sectional study of
the U.S. population (CDC 2004). The
1999–2000 NHANES sample included
96 pregnant women and 271 nonpregnant
women between 18 and 40 years of age (Barr
et al. 2004; CDC 2004). We applied no sam-
ple weights to the NHANES data.
For statistical analyses, we present results
that are not adjusted for creatinine levels. All
analyses were repeated with creatinine-adjusted
values to confirm our results. Analyses were
conducted using STATA software (version 8.2;
StataCorp).
Results
Demographic characteristics. Eighty-ﬁve per-
cent of CHAMACOS study participants were
born in Mexico, with 48% having spent
< 5 years in the United States. The mean age
of participating women was 26 years, and
nearly all lived within 200% of the federal
poverty level. Twenty-eight percent of women
were employed as farm workers at some point
during their pregnancy, and 81% percent
shared a home with at least one agricultural
worker during their pregnancy. Additional
demographic information on this population
is presented in Eskenazi et al. (2004).
Creatinine. Creatinine levels consistently
decreased from the first prenatal sample
through postpartum, with median levels of
98.3 mg/dL [interquartile range (IQR) =
51.6–139.3], 90.6 mg/dL (IQR = 60.8–130.7),
and 85.2 mg/dL (IQR = 51.6–122.4) at the
ﬁrst prenatal, second prenatal, and postpartum
sampling times, respectively. This trend is con-
sistent with medical reference data that indicate
lower creatinine excretion in later trimesters
and early postpartum (Becker et al. 1992;
Davison et al. 1980; Davison and Noble 1981).
Urinary metabolite concentration data.
Tables 1 and 2 present the unadjusted and
the creatinine-adjusted geometric means, per-
centiles, and ranges for the six DAP metabo-
lites and total diethyl and dimethyl phosphate
molar concentrations at each of the three
sampling points. Postpartum urinary metabo-
lite levels were consistently higher than the
prenatal samples, with median unadjusted
total DAP metabolite levels of 102.8 nmol/L
(IQR = 37.7–277.5), 106.8 nmol/L (IQR =
58.1–223.9), and 227.2 nmol/L (IQR =
96.0–554.6) and median creatinine-adjusted
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(IQR = 56.3–316.0), 126.4 nmol/L (IQR =
68.8–237.8), and 283.5 nmol/L (IQR =
109.8–730.3) at the ﬁrst prenatal, second pre-
natal, and postpartum sampling times, respec-
tively. Detection frequencies for dimethyl,
diethyl, and total DAP metabolites were
higher at the second prenatal and postpartum
sampling points than at the ﬁrst prenatal sam-
pling point. Dimethyl phosphate metabolite
levels were higher than diethyl metabolites, a
ﬁnding consistent with previous study results
in other populations (Barr et al. 2004; CDC
2001, 2003; Fenske et al. 2000).
As presented in Tables 1 and 2, postpar-
tum diethyl, dimethyl, and DAP metabolite
levels were higher across the entire distribution
compared with the prenatal sampling points.
Figure 1 presents a scatter plot of the preg-
nancy and postpartum total urinary DAP
metabolite levels by days before and after deliv-
ery. Metabolite levels vary widely both before
and after birth, although there is greater vari-
ability immediately after birth. Paired t-tests for
total DAP levels found signiﬁcant mean differ-
ences between prenatal and postpartum meas-
ures. The mean difference in metabolite levels
between the ﬁrst and second prenatal sample
was 109.0 nmol/L (p = 0.98), but the mean dif-
ference between the ﬁrst prenatal and postpar-
tum samples was 423.4 nmol/L (p < 0.001),
and between the second prenatal and postpar-
tum sampling points was 566.2 nmol/L
(p < 0.001). The within-individual variability
across sampling points was about twice the
between-individual variability (SD = 1.09 and
0.40, respectively).
The proportions of women with urinary
metabolite levels increasing between the ﬁrst
and second prenatal samples, first prenatal
sample and postpartum, and second prenatal
sample and postpartum were 53, 65, and 66%,
respectively. Thus, there was an approximately
even chance of either decreasing or increasing
metabolite levels during pregnancy, whereas a
signiﬁcantly higher proportion of women had
higher levels after delivery compared with pre-
natal levels (binary test of proportions p <
0.001). Identical trends were found within
each season, indicating that the pattern is preg-
nancy related and not a temporal trend (data
not shown). Creatinine adjustment enhanced
the difference between prenatal and post-
partum levels [mean difference = 791.3 and
970.4 nmol/g (p < 0.001) for the ﬁrst prenatal
vs. postpartum samples and second prenatal vs.
postpartum samples, respectively].
We found a clear upward shift in the ratio
of the diethyl phosphate metabolite DEP com-
pared with the diethyl thiophosphate metabo-
lites (DETP, DEDTP) between the prenatal
and postpartum samples. The average ratios
were 2.5 (SD = 6.0), 1.2 (SD = 3.5), and 8.8
(SD = 20.7) for the prenatal 1, prenatal 2, and
postpartum samples, respectively. Similarly, the
median ratios were 0.9, 0.2, and 3.2 for the
prenatal 1, prenatal 2, and postpartum sam-
ples, respectively. The ratios of DMP to
DMTP + DMDTP, however, remained rela-
tively constant across the sampling time points.
The median DMP:(DMTP + DMDTP) ratios
were 0.3, 0.4, and 0.3 for the prenatal 1, pre-
natal 2, and postpartum samples, respectively.
Spearman correlations between the three
sampling time points for the diethyl phosphate
metabolites ranged from 0.03 to 0.07 (p = 0.4),
for dimethyl phosphate metabolites ranged
from 0.05 to 0.10 (p < 0.05–0.3), and for the
total DAP metabolites ranged from 0.04 to
0.13 (p < 0.01–0.3). Overall, the correlation
analyses indicated little or no correlation
between the different sampling times. Within
each sampling time cross-section (prenatal
sample 1, prenatal sample 2, and postpartum),
the correlations of dimethyl and diethyl phos-
phate metabolites were 0.43 (p < 0.01), 0.30
(p < 0.01), and 0.29 (p < 0.01), respectively.
This finding suggests that some participants
were exposed simultaneously to dimethyl and
diethyl OP pesticides.
Comparison with NHANES data. Tables
3 and 4 present unadjusted and creatinine-
adjusted geometric means, percentiles, and
ranges for the total diethyl and dimethyl
phosphate molar concentrations among preg-
nant and nonpregnant women from the
NHANES population. Within the NHANES
sample, DAP metabolite levels were not sig-
nificantly different between pregnant and
nonpregnant women or between Mexican-
American and non-Hispanic women (data
not shown) (Barr et al. 2004). Thus, Figure 2
shows data for CHAMACOS women and all
women between 18 and 40 years of age in the
NHANES sample.
The distribution of total DAP metabolite
levels for CHAMACOS women’s first and
second prenatal visits was signiﬁcantly higher
than NHANES levels (Kolgomorov-Smirnov
D = 0.16, p < 0.001, and D = 0.18, p < 0.001,
respectively). When we further examined the
distribution using quantile regression, we
found that, for the first prenatal samples,
CHAMACOS total DAP metabolite levels
were higher than NHANES levels at the 75th
and 90th percentiles (p < 0.04 and p = 0.001,
respectively); for the second prenatal samples,
however, CHAMACOS total DAP metabolite
levels were higher than NHANES levels at the
25th and 50th percentiles (p < 0.001 and p <
0.05, respectively) (Figure 2). The distribu-
tions of dimethyl and diethyl metabolite levels
for CHAMACOS women were significantly
higher than the NHANES levels in the first
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Table 1. OP urinary metabolite levels at three time points, during pregnancy, and postpartum (nmol/L).a
Detection Geometric Percentile
Sample frequency (%) mean Range 50th 75th 90th
Prenatal sample 1 (n = 590)
DMP 50.3 14.6 3.3–1190.5 6.7 37.3 104.8
DMTP 65.6 30.0 0.9–7042.3 28.9 119.7 331.0
DMDTP 48.6 9.6 0.4–26582.3 4.5 25.9 136.7
Total DM 80.2 82.9 4.8–34362.6 74.2 232.7 648.0
DEP 60.4 7.7 0.9–1039.0 5.3 16.9 46.2
DETP 49.1 4.4 0.4–417.6 2.5 7.6 24.1
DEDTP 45.6 1.4 0.4–236.6 1.1 2.0 4.8
Total DE 74.3 16.7 1.7–1319.3 14.1 32.2 70.9
Total DAP (n = 581) 88.5 112.6 8.2–34438.1 102.8 277.5 731.6
Prenatal sample 2 (n = 498)
DMP 71.5 13.6 3.4–498.7 12.0 35.0 75.3
DMTP 97.6 37.3 1.0–2417.7 42.4 93.3 230.0
DMDTP 57.6 4.1 0.4–1456.0 6.6 20.3 72.6
Total DM 99.6 76.4 4.8–4057.6 76.3 156.3 338.6
DEP 39.8 3.3 0.9–585.3 0.9 17.2 43.9
DETP 98.6 11.5 0.4–408.4 12.5 29.1 50.4
DEDTP 12.3 0.5 0.4–93.6 0.4 0.4 2.3
Total DE 98.8 20.7 1.7–735.1 22.6 44.1 91.6
Total DAP (n = 495) 100.0 113.3 7.1–4098.3 106.8 223.9 421.7
Postpartum (n = 489)
DMP 67.1 27.7 3.4–21855.5 29.3 86.2 293.2
DMTP 85.9 60.0 1.0–20576.7 70.6 225.3 721.5
DMDTP 56.9 3.9 0.4–1329.1 4.0 15.8 61.6
Total DM 93.7 169.9 4.8–21857.3 162.4 444.9 1321.4
DEP 81.4 14.4 0.9–658.1 17.5 41.3 91.4
DETP 65.9 3.6 0.4–595.2 3.5 10.6 23.2
DEDTP 29.2 0.7 0.4–18.2 0.4 1.1 2.8
Total DE 92.2 25.0 1.7–665.6 25.7 58.4 128.1
Total DAP (n = 488) 97.1 229.5 6.5–21866.6 227.2 554.6 1348.6
Abbreviations: DE, diethyl metabolites; DM, dimethyl metabolites.
aDetection limits from multiple batches of urinary metabolite data: DMP = 0.6–1.2 µg/L; DMTP = 0.2–1.1 µg/L; DMDTP =
0.08–1.0 µg/L; DEP = 0.2–0.8 µg/L; DETP = 0.09–0.6 µg/L; DEDTP = 0.05–0.3 µg/L. Values below detection limit = LOD/√2,
consistent with NHANES data published by CDC (2003).(dimethyl: D = 0.24, p < 0.001; diethyl: D =
0.28, p < 0.001) and second (dimethyl: D =
0.19, p < 0.001; diethyl: D = 0.24, p < 0.001)
prenatal visits. Again using quantile regres-
sion, we found that dimethyl metabolite levels
were consistently higher across all quartiles at
the ﬁrst prenatal visit (p ≤ 0.05 at 25th, 50th,
and 75th percentiles; p < 0.01 at 90th per-
centile), but only signiﬁcantly higher for the
25th and 50th percentiles at the second pre-
natal visit (p < 0.001 and p < 0.01, respec-
tively). Conversely, diethyl metabolite levels
were signiﬁcantly higher than NHANES val-
ues at only the 25th percentile for the ﬁrst pre-
natal visit (p < 0.001), but were signiﬁcantly
higher at all quartiles for the second prenatal
visit (p ≤ 0.001 at 25th, 50th, 75th, and 90th
percentiles).
In the postpartum period, total DAP,
dimethyl phosphate, and diethyl phosphate
metabolite levels from the CHAMACOS
women were higher than levels for NHANES
women 18–40 years of age across the distribu-
tion (D = 0.31, p < 0.001; D = 0.30, p <
0.001; and D = 0.26, p < 0.01 for total DAP,
dimethyl, and diethyl metabolites, respec-
tively). Using quantile regression, we found
that total DAP, dimethyl phosphate, and
diethyl phosphate metabolite levels were sig-
nificantly higher than NHANES levels at
every quartile (p < 0.001 at 25th, 50th, 75th,
and 90th percentiles for DAPs, dimethyl and
diethyl phosphate metabolites, respectively).
Creatinine levels in CHAMACOS preg-
nancy samples were no different than in
NHANES pregnancy samples. However, non-
pregnant NHANES women had signiﬁcantly
higher creatinine levels than did pregnant
NHANES women, which is consistent with
known biologic changes that occur during
pregnancy (Becker et al. 1992; Davison and
Noble 1981; Davison et al. 1980). CHAMA-
COS participants’ creatinine-adjusted total
dimethyl and diethyl phosphate and DAP
metabolite levels were signiﬁcantly higher than
creatinine-adjusted levels for NHANES
women 18–40 years of age (data not shown).
In fact, the difference between the creatinine-
adjusted DAP metabolite levels for the two
populations was larger than the difference we
found for unadjusted levels (data not shown).
Discussion
In this initial study of serial DAP metabolite
levels in pregnant and early postpartum
women, we detected measurable levels of DAP
metabolites in nearly all urine samples col-
lected from low-income women in the agricul-
tural region of the Salinas Valley, California.
Levels in this population were substantially
higher than for the U.S. women of compara-
ble age who participated in the NHANES
1999–2000 study. We have noted in our serial
sampling that, although median metabolite
levels in urine collected at approximately 13
and 26 weeks’ gestation were similar, post-
partum metabolite levels were about double
the pregnancy levels. In addition, we found a
clear upward shift in the ratio of the diethyl
phosphate metabolite DEP compared with
the thiophosphate metabolites (DETP +
DEDTP) between the women’s prenatal and
postpartum samples. Because DEP is a known
breakdown product of the bioactivated oxon
form of diethyl OP pesticides (e.g., chlorpyri-
fos-oxon, diazinon-oxon, etc.), this shift in
metabolite ratios may indicate pregnancy-
related changes in hepatic cytochrome P450
metabolism (Needham 2005). However, the
ratios of the dimethyl OP pesticides remained
relatively constant across the sampling time
points. Thus, we have no clear explanation for
this finding. Creatinine adjustment accentu-
ated the difference between prenatal and post-
partum metabolite levels in the postpartum
period. Women in this largely agricultural
cohort had median postpartum urinary DAP
metabolite levels that were 2.5 times higher
than those for NHANES women.
We cannot readily explain the apparent
increase in OP metabolite levels and the
upward shift in the ratio of DEP to DETP +
DEDTP in the postpartum period. One possi-
ble explanation is that the physiologic changes
that occur during pregnancy increase the body’s
capacity to store OP pesticides and/or their
metabolites, but that these excess stores are
excreted soon after delivery. During pregnancy,
women retain approximately 4–6 L ﬂuid, gain
approximately 3.4 kg fat, and increase their
blood volume by 40–45% (Cunningham et al.
1997); these changes may represent new com-
partments where OP pesticides or metabolites
Pesticide exposures of pregnant women
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Table 2. Creatinine-adjusted OP urinary metabolite levels at three time points during pregnancy and postpartum
(nmol/g).a
Detection Geometric Percentile
Sample frequency (%) mean Range 50th 75th 90th
Prenatal sample 1 (n = 589)
DMP 50.2 17.3 1.2–3958.3 13.4 41.5 156.7
DMTP 65.6 35.5 0.7–7027.0 33.7 123.0 398.3
DMDTP 48.6 11.3 0.1–24298.2 9.5 28.3 137.1
Total DM 80.2 98.2 3.3–31410.1 85.1 258.7 728.4
DEP 60.4 9.2 0.4–1749.1 8.2 22.1 47.8
DETP 49.1 5.3 0.2–1131.8 4.7 9.5 25.5
DEDTP 45.6 1.6 0.1–242.8 1.4 3.1 6.3
Total DE 74.3 19.8 0.8–2221.0 18.1 36.4 83.5
Total DAP (n = 580) 88.5 133.4 7.0–31479.1 112.7 316.0 792.3
Prenatal sample 2 (n = 498)
DMP 71.5 15.8 1.4–710.9 15.2 40.4 89.8
DMTP 97.6 43.2 0.3–2609.1 45.5 109.9 237.8
DMDTP 57.6 4.7 0.1–862.1 6.3 23.3 69.8
Total DM 99.6 88.3 2.8–3485.8 82.0 182.1 424.7
DEP 39.8 3.8 0.3–488.5 1.9 18.8 45.3
DETP 98.6 13.3 0.4–472.4 15.0 32.4 65.8
DEDTP 12.3 0.6 0.1–82.3 0.5 0.8 2.1
Total DE 98.8 23.9 1.0–775.3 25.8 51.6 108.5
Total DAP (n = 495) 100.0 130.9 8.8–3724.8 126.4 237.8 478.6
Postpartum (n = 489)
DMP 67.1 35.2 1.1–86109.2 30.5 130.5 429.2
DMTP 85.9 76.3 0.3–34011.1 93.3 322.0 1099.6
DMDTP 56.9 4.9 0.1–1653.1 5.5 20.0 78.0
Total DM 93.7 216.0 2.5–93692.5 213.0 654.6 1796.7
DEP 81.3 18.3 0.4–795.3 22.4 52.9 115.2
DETP 65.9 4.6 0.2–1608.6 5.2 14.3 32.0
DEDTP 29.2 0.9 0.1–95.2 0.8 1.7 4.0
Total DE 92.2 31.8 1.0–1612.1 34.1 77.2 144.2
Total DAP (n = 488) 97.1 292.2 5.2–93798.6 283.5 730.3 1936.3
Abbreviations: DE, diethyl metabolites; DM, dimethyl metabolites.
aDetection limits from multiple batches of urinary metabolite data are given in Table 1. Values below detection limit = LOD/√2,
consistent with NHANES data published by CDC (2003).
Figure 1. Total DAP urinary metabolite levels by
days before and after delivery (n = 535 CHAMACOS
women). The y-axis is truncated at 10,000 nmol/L,
excluding five postpartum samples with higher
DAP measurements. Prenatal data are shown for
pregnancies with a known delivery date; 67 sam-
ples from 61 women who miscarried or dropped
from the study before delivery are excluded from
this graph. Delivery = day 0.
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)could be stored until parturition. Conversely,
urinary frequency and glomerular filtration
increase during pregnancy (Becker et al. 1992;
Cunningham et al. 1997; Davison et al. 1980;
Davison and Noble 1981), suggesting that
metabolite excretion may occur more efﬁciently
in the prenatal period than postpartum. In
addition, pregnancy-related changes in partici-
pants’ diet probably occurred over the course of
this study. However, because it is unlikely that
the women began eating more fruits and veg-
etables contaminated with pesticide residues in
the peripartum period, it is not known how
such dietary factors could explain the observed
changes in DAP metabolite levels postpartum.
Finally, we found that, in the CHAMACOS
population, pregnant and postpartum women’s
urinary creatinine levels were lower than those
of the nonpregnant women in NHANES. This
is consistent with known biologic changes that
occur during pregnancy (Becker et al. 1992;
Davison and Noble 1981; Davison et al. 1980)
and again demonstrates the many metabolic
differences between pregnant and nonpregnant
women. Further research is needed to deter-
mine which physiologic and dietary changes, if
any, affect the excretion of OP metabolites. In
the absence of this information, it is unclear
whether prenatal or postpartum metabolite
levels more accurately reﬂect exposures to OP
pesticides during pregnancy.
As has been reported in previous studies
(Barr et al. 2004; CDC 2001, 2003; Fenske
et al. 2002), CHAMACOS participants’
dimethyl metabolite levels consistently
exceeded diethyl levels, with DMTP predom-
inating. The molar ratio of dimethyl to
diethyl metabolites in participants’ urine is
9:1, which is higher than would be expected
given the 3:2 ratio of dimethyl to diethyl OP
pesticides that the California Department of
Pesticide Regulation reports are used in the
Salinas Valley (California Department of
Pesticide Regulation 2001). This discrepancy
may be explained by the longer environmen-
tal half-lives of dimethyl than diethyl OP pes-
ticides or by alternate exposure pathways,
such as diet and home pesticide use, which we
have not explored here. Regardless of the
exposure pathway, the signiﬁcant correlations
we observed between dimethyl and diethyl
phosphate metabolites within each sampling
time point (Spearman r = 0.29–0.43) suggest
that some participants may experience con-
current exposures to dimethyl and diethyl OP
pesticides.
This study has several limitations. We have
treated urinary DAP metabolite levels as an
indicator of exposure to OP pesticides. Recent
research suggests, however, that urinary
metabolites may reﬂect not only an individual’s
contact with pesticide parent compounds, but
also contact with metabolites present in the
environment (Lu et al. 2005). Lu et al. (2005)
have recently reported that DAP metabolites
are present in fresh fruit juices as a result of OP
pesticide degradation. It is not currently
known whether exposure to DAP metabolites
would result in the intact excretion of these
compounds. Findings from one animal study
suggest that exposure to diethyl phosphate
metabolites results predominately in the excre-
tion of inorganic phosphate (Imaizumi et al.
1993). Nonetheless, DAP metabolite levels
may overestimate a woman’s exposure to OP
pesticides and, in fact, reﬂect her exposure, in
part, to metabolites already present in her
environment.
Another limitation of this study is that we
have relied on metabolite levels from single
spot urine samples collected at different times
of the day to characterize participants’ expo-
sure. Kissel et al. (2005) have reported that
same-day spot samples collected from chil-
dren vary in metabolite concentration, but
that the ﬁrst morning void tends to reﬂect the
day’s total metabolite excretion better than do
other spot samples (Kissel et al. 2005). The
lack of correlation between CHAMACOS
participants’ metabolite levels at different
time points may be due, at least in part, to
this sampling scheme. The high intraindivid-
ual variability we observed suggests that addi-
tional spot samples, a same-time sampling
scheme (e.g., first morning voids for each
woman at each time point), or perhaps even
24-hr samples might better characterize
women’s cumulative exposure to OP pesti-
cides during pregnancy.
Further, we assigned an imputed value of
the LOD/√2 to levels below the detection
limit. This method is identical to procedures
adopted by the CDC and frequently used in
exposure assessment (Barr et al. 1999, 2004;
CDC 2003; Hornung and Reed 1990).
However, results may differ depending on
how LODs are considered across studies and
if LODs differ in comparison populations.
Bradman et al.
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Table 3. Urinary DAP concentrations (nmol/L) among pregnant women (n = 96) and nonpregnant women of
childbearing age (n = 271) in NHANES 1999–2000.
Detection Geometric Percentile
frequency (%) mean Range 50th 75th 90th
Pregnant womena
Total DM 82.5 48.1 4.5–2606.6 50.0 195.7 421.1
Total DE 75.3 8.2 1.5–296.1 8.9 20.3 42.8
Total DAP 92.8 70.5 6.0–2610.5 72.0 246.2 437.7
Nonpregnant women of
childbearing ageb
Total DM 82.6 52.0 4.5–19721.9 54.8 159.4 378.5
Total DE 76.8 11.6 1.5–1157.1 13.7 34.0 56.7
Total DAP 90.9 82.3 2.3–19724.1 90.0 201.0 417.6
Abbreviations: DE, diethyl metabolites; DM, dimethyl metabolites.
aThe distributions of OP metabolite levels in pregnant and nonpregnant women of childbearing age in the NHANES study
were not statistically different (see “Data analysis”). Pregnant women ranged in age from 15 to 50 years. b Total DAP n = 270
because of missing DMTP data.
Table 4. Creatinine-adjusted urinary DAP concentrations (nmol/g creatinine) among pregnant women (n =
96) and nonpregnant women of childbearing age (n = 271) in NHANES 1999–2000.
Detection Geometric Percentile
frequency (%) mean Range 50th 75th 90th
Pregnant womena
Total DM 82.5 49.8 1.5–3727.3 50.7 168.2 408.4
Total DE 75.3 8.5 0.7–308.5 8.4 28.4 55.8
Total DAP 92.8 73.0 3.1–3783.0 75.2 213.8 435.8
Nonpregnant women of
childbearing ageb
Total DM 82.6 41.3 1.4–16713.5 44.8 125.2 313.3
Total DE 76.8 9.3 0.4–2492.8 9.2 23.0 55.8
Total DAP 90.9 65.5 2.3–16715.3 67.1 155.9 370.3
Abbreviations: DE, diethyl metabolites; DM, dimethyl metabolites.
aThe distributions of OP metabolite levels in pregnant and nonpregnant women of childbearing age in the 1999–2000
NHANES study were not statistically different (see “Data analysis”). Pregnant women ranged in age from 15 to 50 years.
bTotal DAP n = 270 because of missing DMTP data.
Figure 2. Total DAP urinary metabolite levels in the
CHAMACOS cohort and NHANES 1999–2000. Error
bars indicate 95% conﬁdence intervals. Statistically
signiﬁcant differences between CHAMACOS sample
and NHANES sample: *p < 0.05; **p < 0.001.
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Further exploration is needed to determine
the appropriate method of comparing large
data sets with different LODs.
In summary, we found that pregnant
women living in an agricultural area had higher
urinary metabolite levels of OP pesticides com-
pared with the general U.S. population. Our
ﬁnding of higher levels in the immediate post-
partum period may have implications for esti-
mating dose during pregnancy and for infant
exposure from breast-feeding. Our future
analyses will explore possible determinants of
exposure—such as ﬁeldwork and proximity to
agricultural ﬁelds—that may explain the high
urinary OP metabolite levels among women in
this agricultural community relative to other
U.S. women. In addition, we will attempt to
clarify whether documented physiologic
changes among these women (e.g., prenatal
weight gain) influenced the degree to which
their prenatal and postpartum metabolite levels
differed.
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